Modelling the impact of earlier initiation on outcomes and costs in the UK Many people with severe asthma have uncontrolled disease and accumulate high lifetime doses of oral corticosteroids (OCS). Although biologic therapies reduce exacerbations and OCS use, current care often follows a failure-based approach to starting biologics (1). Severe…